Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bipolar Disorder is a type of affective disorder in which the patient has both manic or mild manic episodes and depressive episodes.Bipolar Disorder Therapeutic refers to treatments for this psychological disorder.
The global Bipolar Disorder Therapeutic market will reach $5.2 billion by 2026. North America accounted for the largest market share due to the rising prevalence of bipolar disorder in North America. This can be attributed to high stress levels, sleep deprivation and the trend of substance abuse among the population. Moreover, government initiatives aimed at raising awareness and supporting people with bipolar disorder are also expected to drive the market growth in the region. For instance, the Center for Mental Health Services (CMHS) of the Substance Abuse and Mental Health Services Administration (SAMHSA) under the U.S. Department of Health and Human Services expanded its support for mental health treatment and recovery in 2016. The Asia-Pacific region is expected to grow at a higher rate, which can be attributed to the high prevalence of mental illness in the region. According to data released by the World Health Organization, India and China are among the countries most affected by mental disorders such as anxiety disorders, schizophrenia, and bipolar disorder. Some governments are allocating funds for bipolar research and conducting awareness campaigns to remove the stigma associated with bipolar disorder and increase treatment and compliance rates among the general population. Scientific and medical institutions are also playing an active role by conducting research and developing new drugs and therapies for bipolar disorder.
Rising prevalence of bipolar disorder due to competitive social pressures, surge in work-life stress among the urban living population, government support for causing awareness about bipolar disorder, and technological advancements that help in accurate detection of emotional and mental state of patients are some of the key factors driving the growth of the Bipolar Disorder Therapeutic market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Bipolar Disorder Therapeutic market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Bipolar Disorder Therapeutic market. Detailed analysis of key players, along with key growth strategies adopted by Bipolar Disorder Therapeutic industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Allergan
Janssen Pharmaceuticals
AstraZeneca
Astellas Pharma
Eli Lilly
GlaxoSmithKline
Bristol-Myers Squibb
By Type:
Antipsychotics
Anticonvulsants
Mood Stabilizers
By End-User:
medical treatment
psychological counselling
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Bipolar Disorder Therapeutic Market
-
1.3 Market Segment by Type
-
1.3.1 China Bipolar Disorder Therapeutic Market Size and Growth Rate of Antipsychotics from 2016 to 2027
-
1.3.2 China Bipolar Disorder Therapeutic Market Size and Growth Rate of Anticonvulsants from 2016 to 2027
-
1.3.3 China Bipolar Disorder Therapeutic Market Size and Growth Rate of Mood Stabilizers from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Bipolar Disorder Therapeutic Market Size and Growth Rate of medical treatment from 2016 to 2027
-
1.4.2 China Bipolar Disorder Therapeutic Market Size and Growth Rate of psychological counselling from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Bipolar Disorder Therapeutic Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Bipolar Disorder Therapeutic by Major Types
-
3.4.1 Market Size and Growth Rate of Antipsychotics
-
3.4.2 Market Size and Growth Rate of Anticonvulsants
-
3.4.3 Market Size and Growth Rate of Mood Stabilizers
4 Segmentation of Bipolar Disorder Therapeutic Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Bipolar Disorder Therapeutic by Major End-Users
-
4.4.1 Market Size and Growth Rate of Bipolar Disorder Therapeutic in medical treatment
-
4.4.2 Market Size and Growth Rate of Bipolar Disorder Therapeutic in psychological counselling
5 Market Analysis by Regions
-
5.1 China Bipolar Disorder Therapeutic Production Analysis by Regions
-
5.2 China Bipolar Disorder Therapeutic Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Bipolar Disorder Therapeutic Landscape Analysis
-
6.1 North China Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
6.2 North China Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
7 Central China Bipolar Disorder Therapeutic Landscape Analysis
-
7.1 Central China Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
7.2 Central China Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
8 South China Bipolar Disorder Therapeutic Landscape Analysis
-
8.1 South China Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
8.2 South China Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
9 East China Bipolar Disorder Therapeutic Landscape Analysis
-
9.1 East China Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
9.2 East China Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
10 Northeast China Bipolar Disorder Therapeutic Landscape Analysis
-
10.1 Northeast China Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
10.2 Northeast China Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
11 Southwest China Bipolar Disorder Therapeutic Landscape Analysis
-
11.1 Southwest China Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
11.2 Southwest China Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
12 Northwest China Bipolar Disorder Therapeutic Landscape Analysis
-
12.1 Northwest China Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
12.2 Northwest China Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Allergan
-
13.1.1 Allergan Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Janssen Pharmaceuticals
-
13.2.1 Janssen Pharmaceuticals Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 AstraZeneca
-
13.3.1 AstraZeneca Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Astellas Pharma
-
13.4.1 Astellas Pharma Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Eli Lilly
-
13.5.1 Eli Lilly Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 GlaxoSmithKline
-
13.6.1 GlaxoSmithKline Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Bristol-Myers Squibb
-
13.7.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Bipolar Disorder Therapeutic Market Size and Growth Rate of Antipsychotics from 2016 to 2027
-
Figure China Bipolar Disorder Therapeutic Market Size and Growth Rate of Anticonvulsants from 2016 to 2027
-
Figure China Bipolar Disorder Therapeutic Market Size and Growth Rate of Mood Stabilizers from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Bipolar Disorder Therapeutic Market Size and Growth Rate of medical treatment from 2016 to 2027
-
Figure China Bipolar Disorder Therapeutic Market Size and Growth Rate of psychological counselling from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Bipolar Disorder Therapeutic Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Bipolar Disorder Therapeutic
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Bipolar Disorder Therapeutic by Different Types from 2016 to 2027
-
Table Consumption Share of Bipolar Disorder Therapeutic by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Antipsychotics
-
Figure Market Size and Growth Rate of Anticonvulsants
-
Figure Market Size and Growth Rate of Mood Stabilizers
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Bipolar Disorder Therapeutic by Different End-Users from 2016 to 2027
-
Table Consumption Share of Bipolar Disorder Therapeutic by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of medical treatment
-
Figure Market Size and Growth Rate of psychological counselling
-
Table China Bipolar Disorder Therapeutic Production by Regions
-
Table China Bipolar Disorder Therapeutic Production Share by Regions
-
Figure China Bipolar Disorder Therapeutic Production Share by Regions in 2016
-
Figure China Bipolar Disorder Therapeutic Production Share by Regions in 2021
-
Figure China Bipolar Disorder Therapeutic Production Share by Regions in 2027
-
Table China Bipolar Disorder Therapeutic Consumption by Regions
-
Table China Bipolar Disorder Therapeutic Consumption Share by Regions
-
Figure China Bipolar Disorder Therapeutic Consumption Share by Regions in 2016
-
Figure China Bipolar Disorder Therapeutic Consumption Share by Regions in 2021
-
Figure China Bipolar Disorder Therapeutic Consumption Share by Regions in 2027
-
Table North China Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table North China Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure North China Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure North China Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure North China Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table North China Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table North China Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure North China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure North China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure North China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table Central China Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table Central China Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure Central China Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure Central China Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure Central China Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table Central China Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table Central China Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure Central China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure Central China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table South China Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table South China Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure South China Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure South China Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure South China Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table South China Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table South China Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure South China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure South China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure South China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table East China Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table East China Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure East China Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure East China Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure East China Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table East China Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table East China Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure East China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure East China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure East China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table Northeast China Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table Northeast China Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure Northeast China Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure Northeast China Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table Northeast China Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table Northeast China Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure Northeast China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure Northeast China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table Southwest China Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table Southwest China Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure Southwest China Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure Southwest China Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table Southwest China Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table Southwest China Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure Southwest China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure Southwest China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table Northwest China Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table Northwest China Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure Northwest China Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure Northwest China Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table Northwest China Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table Northwest China Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure Northwest China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure Northwest China Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Janssen Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals
-
Table Product and Service Introduction of Janssen Pharmaceuticals
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
